Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Admicom Oyj ADMCM Jan 22, 2020 78.20 -0.76   
 Afarak Group AFAGR Jan 22, 2020 0.50 -0.60   
 Ahlstrom-Munksjö AM1 Jan 22, 2020 14.82 -0.54   
 Ahlstrom-Munksjö AM1S Jan 22, 2020 155.60 -0.51   
 Ahola Transport AHOLA Jan 22, 2020 0.88 +0.57   
 Aktia Bank AKTIA Jan 22, 2020 9.72 -0.31   
 Alma Media ALMA Jan 22, 2020 9.14 +1.78   
 Altia ALTIA Jan 22, 2020 8.50 0.00   
 Apetit APETIT Jan 22, 2020 8.40 -0.47   
 Asiakastieto Group ATG1V Jan 22, 2020 37.30 +0.54   
 Aspo ASPO Jan 22, 2020 7.96 -0.50   
 Aspocomp Group ACG1V Jan 22, 2020 6.04 +1.34   
 Atria A ATRAV Jan 22, 2020 10.22 +2.20   
 Basware BAS1V Jan 22, 2020 26.45 +1.34   
 BBS-Bioactive Bone Substitutes BONEH Jan 22, 2020 3.88 -9.35   
 Biohit B BIOBV Jan 22, 2020 3.41 +1.19   
 Bittium BITTI Jan 22, 2020 7.19 -0.42   
 CapMan CAPMAN Jan 22, 2020 2.34 +0.21   
 Cargotec CGCBV Jan 22, 2020 33.64 -1.12   
 Caverion CAV1V Jan 22, 2020 8.11 +0.25   
 Citycon CTY1S Jan 22, 2020 9.72 +0.52   
 Componenta CTH1V Jan 22, 2020 0.12 +0.43   
 Consti Yhtiöt CONSTI Jan 22, 2020 7.14 +1.71   
 Cramo CRA1V Jan 22, 2020 13.73 +0.07   
 Detection Technology DETEC Jan 22, 2020 27.80 -0.71   
 Digia DIGIA Jan 22, 2020 4.60 +1.32   
 Digitalist Group DIGIGR Jan 22, 2020 0.05 -1.74   
 DNA DNA Jan 22, 2020 20.86 0.00   
 Dovre Group DOV1V Jan 22, 2020 0.30 +1.68   
 EAB Group EAB Jan 22, 2020 3.04 -4.40   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK